Skip to main content
About the Institute
  • English
  • Français
  • Español
  • Russian
  • Portuguese
  • Polish

Breadcrumb

  1. Home
  2. Gastroenterology
  3. The mucin-microbiota pair - central to the development of gastric cancer?
  • Our publications
    • News
    • Microbiota Mag
    • Thematic pages
    • Experts' point of view
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • About us
    • International Microbiota Observatory
    • Press room
    • Partnerships
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
    • Xpeer App
  • Useful documents
    • Infographics
    • IBS Diagnosis Check List
    • Patients Stories

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

Lay public section

Find here your dedicated section
Gastroenterology
Gynecology
Pediatrics
Dermatology

Breadcrumb

  1. Home
  2. Gastroenterology
  3. The mucin-microbiota pair - central to the development of gastric cancer?
Gastroenterology

The mucin-microbiota pair - central to the development of gastric cancer?

Cancer
Gastroenterology Oncology

One study suggests that intestinal mucins have a key role in the dysbiosis that sets in as gastric cancer progresses and in its prognosis. The mucins are said to promote the stomach’s colonization by pro-inflammatory oral bacteria.

Gastroenterology
Gynecology
Pediatrics
Dermatology
  • Our publications
    • News
    • Microbiota Mag
    • Thematic pages
    • Experts' point of view
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • About us
    • International Microbiota Observatory
    • Press room
    • Partnerships
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
    • Xpeer App
  • Useful documents
    • Infographics
    • IBS Diagnosis Check List
    • Patients Stories

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

Lay public section

Find here your dedicated section

Sources

This article is based on scientific information

Sharing is caring

Your colleagues might be interested in this topic. Why not share it?

  • Facebook
  • Twitter
  • LinkedIn
  • Mail

About this article

Created 21 September 2023
Updated 26 September 2023

Prognosis of gastric cancer is difficult as the absence of symptoms in the initial stages of the disease delays its management. Although genetics and environmental factors play a part, the most common cause is Helicobacter pylori infection, which is thought to promote the subsequent arrival of other bacteria (from the mouth or intestines) involved in the tumor’s growth. The (sidenote: Mucin Glycoproteins that are the main component of mucus, the complex viscoelastic gel that covers the secretory epithelial cells, protecting them against foreign particles and pathogenic organisms. Source : Demouveaux B, Gouyer V, Magnien M, et al. La structure des mucines conditionne les propriétés viscoélastiques des gels de mucus [Gel-forming mucins structure governs mucus gels viscoelasticity]. Med Sci (Paris). 2018 Oct;34(10):806-812. French. ) secreted by the digestive mucus seem to also play a role: specific phenotypes of the mucins (gastric in the early stages and intestinal in the advanced stages) are expressed in adenocarcinomas. Is this enough to suggest that there are mucin-microbiota signatures in gastric adenocarcinomas? This is the hypothesis of one Belgian team in any case.

5th Gastric cancer is the fifth most common cancer type.

4th Gastric cancer is the fourth leading cause of cancer-related deaths worldwide.

(sidenote: Sung H, Ferlay J, Siegel RL et al. Statistiques mondiales sur le cancer 2020 : Estimations GLOBOCAN de l'incidence et de la mortalité dans le monde pour 36 cancers dans 185 pays. CA Cancer J Clin. 2021 ; 71 : 209–49. )

A mucin-dependent prognosis

Analysis of the tumor and adjacent non-tumorous tissue in 108 patients who underwent surgery for gastric cancer and biopsies of 20 patients who underwent a gastroscopy due to functional dyspepsia (with no tumor) enabled measurement of the relative expression of gastric mucins (MUC1, MUC5AC and MUC6) and intestinal mucins (MUC2, MUC4 and MUC13). The results show that these three gastric mucins are principally expressed in tumor-free tissue (adjacent or biopsies). Conversely, the overexpression of the intestinal mucin MUC13 proves to be typical of tumors and correlates to a poor prognosis in the development of the cancer.

A mucin-microbiota connection

In terms of bacteria (identified via sequencing of the 16S rRNA gene), several taxa previously associated with gastro-intestinal cancers, in particular Corynebacterium, Fusobacterium, Streptococcus, Porphyromonas and Prevotella, differed significantly between tumorous tissue, adjacent non-cancerous tissue and biopsy tissue. In addition, connections between the bacteria present and the specific phenotype of the mucins in contact with the tumor environment were observed: Helicobacter was more present in tumors without mucins; the taxa (including some that were previously described as oral pathogens) Prevotella, Veillonella and Neisseria seemed to develop more in tumors overexpressing MUC13.

Toward a prognosis for gastric cancer?

Mucins could therefore play a key role in the prognosis of gastric cancer and the formation of the tumor microbiota. An increase in certain oral bacterial taxa associated with an MUC13 overexpression could signal the presence of the disease. Could the mucin-microbiota pair be used as an early marker of the disease? Perhaps, although we should remain cautious for now, as other studies will be required before we can confirm these initial conclusions.

Sources

Oosterlinck B, Ceuleers H, Arras W, et al. Mucin-microbiome signatures shape the tumor microenvironment in gastric cancer. Microbiome. 2023 Apr 21;11(1):86.

Tags
Cancer Dysbiosis Test

en_view en_sources

    See also

    Human microbiota: interconnected network that determines balance between health and illness?
    Digestive cancers and intestinal microbiota: from oncogenesis to response to treatment
    Created 21 September 2023
    Updated 26 September 2023

    About this article

    To know more about this topic.

    Main topic

    Cancer

    Medical practice

    Gastroenterology Oncology

    Content type

    News
    Gastroenterology

    Probiotics: what exactly are we talking about?

    From the Latin pro and Greek bios meaning “for life”, the term “probiotic” was suggested over 60 years ago,...

    Find out more

    How do you choose a probiotic for your patient?

    Faced with a plethora of products on the market, it's not always easy for health professionals to suggest a...

    Find out more

    Gut microbiota and Clostridioides difficile

    Overview By Pr. Gianluca IaniroDigestive Disease Center, Fondazione Policlinico “A. Gemelli” IRCCS, Rome, ...

    Find out more

    Impact of antibiotics on the gut microbiota, does it matter?

    Overview By Pr. Francisco GuarnerDigestive System Research Unit, University Hospital Vall d’Hebron, Barcel...

    Find out more

    From diarrhea to chronic diseases: the well-documented consequences of antibiotic-related gut microbiota dysbiosis

    Antibiotic treatment may sometimes take place without any...

    Find out more

    Resilience of healthy adult gut microbiota following antibiotic exposure

    Commented articles - Adults' section By Pr. Harry SokolG...

    Find out more

    Antibiotic resistance: the lung microbiota pays a heavy price

    Broad-spectrum antibiotics used for treating lung infections are regarded as one of the principal contribut...

    Find out more

    Your IBS Diagnosis Check List

    How many patients suffering from gut disorder do you see per week? How many are diagnosed with Irritable Bo...

    Find out more

    Continue reading

    News
    23.11.2022

    Is gut dysbiosis a risk factor for HIV infection?

    Read the article
    22.11.2023

    Is vaginal microbiota transfer the new miracle for C-section babies?

    Read the article
    26.10.2023

    Can antibiotics promote the growth of harmful bacteria in the gut?

    Read the article
    Intestinal bacteria, illustration.
    24.08.2023

    Everything you need to know about probiotics

    Read the article
    20.10.2023

    Fecal transplant: “where, when, how much” needed to optimize effects on IBS?

    Read the article
    26.07.2023

    Unexpected effect of famous antibiotic on fungal microbiota

    Read the article
    29.08.2023

    Massive amounts of antibiotic resistance genes found in clouds

    Read the article
    Antibiotiques : le mycobiote des nourrissons sous influence
    16.08.2022

    The effect of antibiotics on infant mycobiota

    Read the article
    What's worth reading about microbiota
    Follow us on X
    Read our thematic folder
    The Janus face of Antibiotics: Life Savers & Microbiota Disrupters
    Microbiota 17 EN
    Check out our latest magazine
    The first 1000 days of life
    • Our publications
      • News
      • Microbiota Mag
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographics
      • IBS Diagnosis Check List
      • Patients Stories

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube

    Lay public section

    Find here your dedicated section
    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology
    • English
    • Français
    • Español
    • Russian
    • Portuguese
    • Polish

    Browse the site

    • Our publications
      • News
      • Microbiota Mag
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographics
      • IBS Diagnosis Check List
      • Patients Stories

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

    Lay public section

    Find here your dedicated section

    Redirection

    You are about to be redirected and leave our website

    • Be redirected
    • Stay on the Biocodex Microbiota Institute's website

    Stay with us !

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    Explore

    27.11.2023

    Predicting the risk of preterm birth through vaginal microbiota

    Read the article

    Antimicrobial resistance: Doctor, your role is essential! Patient, your behavior is key!

    In November, Biocodex and the Biocodex Microbiota Institu...

    Find out more
    22.11.2023

    Is vaginal microbiota transfer the new miracle for C-section babies?

    Read the article

    Stay updated

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    • Our publications
      • News
      • Microbiota Mag
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographics
      • IBS Diagnosis Check List
      • Patients Stories

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology

    Lay public section

    Find here your dedicated section

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

    © 2022 Biocodex. All rights reserved.

    • Cookies Policy
    • Data protection policy
    • GTU
    • Sitemap
    • Cookies settings
    • Digital accessibility : partially compliant
    Biocodex logo